Table 1. CD2/CD28- and LPS- induced cytokine and chemokine production before (T0), 1 (T1) and 6 (T2) months after deployment.
| T0 | T1 | T2 | |||||||
| Mean | SD | N | Mean | SD | N | Mean | SD | N | |
| CD2/CD28 | |||||||||
| IL-2 a | 1082.6 | 1369.1 | 995 | 1243.9 | 1591.0 | 819 | 1387.1 | 1654.1 | 743 |
| IL-4 a | 79.2 | 84.5 | 1002 | 115.2 | 129.4 | 814 | 125.2 | 135.0 | 742 |
| IL-5 a | 613.1 | 1008.1 | 983 | 642.4 | 1026.0 | 811 | 715.2 | 1088.4 | 736 |
| IL-6 a | 1229.5 | 1348.6 | 991 | 977.1 | 831.0 | 810 | 937.1 | 843.6 | 742 |
| IL-10 b | 432.7 | 356.8 | 999 | 543.3 | 454.4 | 817 | 589.1 | 440.7 | 744 |
| TNF-α a | 560.8 | 475.7 | 1000 | 837.0 | 853.1 | 802 | 1209.3 | 1089.8 | 733 |
| IFN-γ a | 20593.2 | 23593.4 | 998 | 21117.9 | 21951.8 | 764 | 28376.0 | 34652.1 | 708 |
| MCP-1 a | 18308.0 | 14514.0 | 998 | 14577.4 | 10102.1 | 817 | 12728.2 | 8818.9 | 741 |
| IP-10 b | 5977.5 | 3485.5 | 994 | 7355.7 | 4539.4 | 818 | 9099.8 | 5977.1 | 744 |
| RANTES a | 7142.0 | 6893.1 | 995 | 6298.5 | 4833.4 | 815 | 5069.5 | 4514.0 | 741 |
| LPS | |||||||||
| IL1-α a | 68.3 | 51.1 | 1002 | 60.1 | 47.0 | 793 | 57.0 | 41.4 | 721 |
| IL1-β b | 314.4 | 227.4 | 996 | 260.6 | 179.0 | 802 | 241.1 | 156.6 | 730 |
| IL-6 b | 2951.7 | 1812.7 | 1008 | 2492.8 | 1988.3 | 806 | 2201.1 | 1286.4 | 712 |
| IL-8 b | 1955.9 | 1144.3 | 1006 | 2048.0 | 1087.3 | 805 | 2069.7 | 1076.8 | 725 |
| IL-10 a | 33.8 | 35.6 | 1006 | 28.8 | 25.5 | 805 | 31.0 | 28.7 | 733 |
| TNF-α a | 851.5 | 677.9 | 1005 | 578.7 | 467.5 | 796 | 489.2 | 385.7 | 729 |
a
log10-transformation applied; b square root-transformation applied.